Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.38% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NAGE · Mar 31, 2023
Niagen Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-23-017204General Corporate
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
52.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
59.93% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-8.72% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.29% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.64% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -20.95%
- Current
- 12.38%
- Delta
- 33.33%
- Previous
- 20.37%
- Current
- 52.79%
- Delta
- 32.42%
- Previous
- 59.40%
- Current
- 59.93%
- Delta
- 0.53%
- Previous
- -25.85%
- Current
- -8.72%
- Delta
- 17.13%
- Previous
- 6.70%
- Current
- 5.29%
- Delta
- -1.41%
- Previous
- 7.97%
- Current
- 5.64%
- Delta
- -2.32%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NAGE Fundamental State →Has State · Niagen Bioscience, Inc. →Transitioned To · NAGE Fundamental State →Transitioned To · NAGE CASH_GENERATION_INCREASED →Transitioned To · NAGE INVENTORY_PRESSURE_INCREASED →Transitioned To · NAGE MARGIN_INCREASED →Transitioned To · NAGE PROFITABILITY_INCREASED →Transitioned To · NAGE R_AND_D_INTENSITY_DECREASED →Transitioned To · NAGE SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.